Chair: Lanetta Bronte-Hall, MD, MPH, MSPH – Foundation for Sickle Cell Disease Research
Chair: Lanetta Bronte-Hall, MD, MPH, MSPH – Foundation for Sickle Cell Disease Research
Chair: Lanetta Bronte-Hall, MD, MPH, MSPH – Foundation for Sickle Cell Disease Research
###Speaker: Lanetta Bronte-Hall, MD, MPH, MSPH – Foundation for Sickle Cell Disease Research
Speaker: Lanetta Bronte-Hall, MD, MPH, MSPH – Foundation for Sickle Cell Disease Research
###Speaker: Avery Dial
Speaker: Avery Dial
###Speaker: Gershwin T. Blyden, MD/PhD – Foundation for Sickle Cell Research
Speaker: Gershwin T. Blyden, MD/PhD – Foundation for Sickle Cell Research
###Speaker: Betty S. Pace, MD – Augusta University
Speaker: Betty S. Pace, MD – Augusta University
###Speaker: Anthony J. Hall, MDCM – Academy of Neurosurgical Physicians, Inc
Speaker: Anthony J. Hall, MDCM – Academy of Neurosurgical Physicians, Inc
###Keynote Speaker: Biree Andemariam, MD – New England Sickle Cell Institute, University of Connecticut Health, Farmington, CT, USA
CE: 1
Keynote Speaker: Biree Andemariam, MD – New England Sickle Cell Institute, University of Connecticut Health, Farmington, CT, USA
###CE: 2
CE: 2
Chair: Cecelia Valrie, PhD (she/her/hers) – Virginia Commonwealth University (Richmond, VA, US)
### she/her/hersSpeaker: Cecelia Valrie, PhD (she/her/hers) – Virginia Commonwealth University (Richmond, VA, US)
Speaker: Cecelia Valrie, PhD (she/her/hers) – Virginia Commonwealth University (Richmond, VA, US)
### she/her/hersSpeaker: Cecelia Valrie, PhD (she/her/hers) – Virginia Commonwealth University (Richmond, VA, US)
Speaker: Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency
Speaker: Cecelia Valrie, PhD (she/her/hers) – Virginia Commonwealth University (Richmond, VA, US)
### she/her/hers @@@ Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency ### 1886479###Speaker###Patient Engagement Coordinator/ Research Consultant ###Piedmont Health Services and Sickle Cell Agency ###Speaker: Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency
### she/her/hersSpeaker: Laila Aziz Mahmood, MD MPH (she/her/hers) – Children's National Medical Center
Speaker: Laila Aziz Mahmood, MD MPH (she/her/hers) – Children's National Medical Center
### she/her/hersSpeaker: Laila Aziz Mahmood, MD MPH (she/her/hers) – Children's National Medical Center
Speaker: Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency
Speaker: Laila Aziz Mahmood, MD MPH (she/her/hers) – Children's National Medical Center
### she/her/hers @@@ Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency ### 1886479###Speaker###Patient Engagement Coordinator/ Research Consultant ###Piedmont Health Services and Sickle Cell Agency ###Speaker: Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency
### she/her/hersSpeaker: Joy Ogunsile (she/her/hers) – Memorial Regional Healthcare
Speaker: Joy Ogunsile (she/her/hers) – Memorial Regional Healthcare
### she/her/hersSpeaker: Joy Ogunsile (she/her/hers) – Memorial Regional Healthcare
Speaker: Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency
Speaker: Joy Ogunsile (she/her/hers) – Memorial Regional Healthcare
### she/her/hers @@@ Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency ### 1886479###Speaker###Patient Engagement Coordinator/ Research Consultant ###Piedmont Health Services and Sickle Cell Agency ###Speaker: Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency
### she/her/hersChair: Ahmar U. Zaidi, MD (he/him/his) – Agios Pharmaceuticals
### he/him/hisSpeaker: Ahmar U. Zaidi, MD (he/him/his) – Agios Pharmaceuticals
Speaker: Ahmar U. Zaidi, MD (he/him/his) – Agios Pharmaceuticals
### he/him/hisSpeaker: Yang Dai, MD, PhD (he/him/his) – Alexion, AstraZeneca Rare Disease
Speaker: Yang Dai, MD, PhD (he/him/his) – Alexion, AstraZeneca Rare Disease
### he/him/hisSpeaker: Adam Wufsus, PhD (he/him/his) – Novo Nordisk, Inc.
Speaker: Adam Wufsus, PhD (he/him/his) – Novo Nordisk, Inc.
### he/him/hisSpeaker: Ben Hsu, MD, PhD (he/him/his) – Sangamo Therapeutics
Speaker: Ben Hsu, MD, PhD (he/him/his) – Sangamo Therapeutics
### he/him/hisSpeaker: Sarah Gheuens, MD, PhD (she/her/hers) – Agios Pharmaceuticals
Speaker: Sarah Gheuens, MD, PhD (she/her/hers) – Agios Pharmaceuticals
### she/her/hersSpeaker: Suvankar Majumdar, MD (he/him/his) – Asklepion Pharmaceuticals
Speaker: Suvankar Majumdar, MD (he/him/his) – Asklepion Pharmaceuticals
### he/him/hisSpeaker: Valerie Cachat, MSN, APRN, CPNP (she/her/hers) – Pfizer
Speaker: Valerie Cachat, MSN, APRN, CPNP (she/her/hers) – Pfizer
### she/her/hersSpeaker: Paul Shore, MD, MS – CSL Behring
Speaker: Paul Shore, MD, MS – CSL Behring
###Chair: Ahmar U. Zaidi, MD (he/him/his) – Agios Pharmaceuticals
Speaker: Yang Dai, MD, PhD (he/him/his) – Alexion, AstraZeneca Rare Disease
Speaker: Adam Wufsus, PhD (he/him/his) – Novo Nordisk, Inc.
Speaker: Ben Hsu, MD, PhD (he/him/his) – Sangamo Therapeutics
Speaker: Sarah Gheuens, MD, PhD (she/her/hers) – Agios Pharmaceuticals
Speaker: Suvankar Majumdar, MD (he/him/his) – Asklepion Pharmaceuticals
Speaker: Valerie Cachat, MSN, APRN, CPNP (she/her/hers) – Pfizer
Speaker: Paul Shore, MD, MS – CSL Behring
Chair: Ahmar U. Zaidi, MD (he/him/his) – Agios Pharmaceuticals
### he/him/his @@@ Yang Dai, MD, PhD (he/him/his) – Alexion, AstraZeneca Rare Disease ### 1916746###Speaker###Senior Medical Director###Alexion, AstraZeneca Rare Disease###Speaker: Yang Dai, MD, PhD (he/him/his) – Alexion, AstraZeneca Rare Disease
### he/him/his @@@ Adam Wufsus, PhD (he/him/his) – Novo Nordisk, Inc. ### 1982912###Speaker###Medical Director, Rare Blood Disorders###Novo Nordisk, Inc.###Speaker: Adam Wufsus, PhD (he/him/his) – Novo Nordisk, Inc.
### he/him/his @@@ Ben Hsu, MD, PhD (he/him/his) – Sangamo Therapeutics ### 1916747###Speaker###Vice President, Clinical Sciences###Sangamo Therapeutics###Speaker: Ben Hsu, MD, PhD (he/him/his) – Sangamo Therapeutics
### he/him/his @@@ Sarah Gheuens, MD, PhD (she/her/hers) – Agios Pharmaceuticals ### 1916748###Speaker###Head of R&D and Chief Medical Officer###Agios Pharmaceuticals###Speaker: Sarah Gheuens, MD, PhD (she/her/hers) – Agios Pharmaceuticals
### she/her/hers @@@ Suvankar Majumdar, MD (he/him/his) – Asklepion Pharmaceuticals ### 1633998###Speaker###Presenter###Asklepion Pharmaceuticals###Speaker: Suvankar Majumdar, MD (he/him/his) – Asklepion Pharmaceuticals
### he/him/his @@@ Valerie Cachat, MSN, APRN, CPNP (she/her/hers) – Pfizer ### 1970700###Speaker###Medical Director###Pfizer###Speaker: Valerie Cachat, MSN, APRN, CPNP (she/her/hers) – Pfizer
### she/her/hers @@@ Paul Shore, MD, MS – CSL Behring ### 1968834###Speaker###Clinical Program Director###CSL Behring###Speaker: Paul Shore, MD, MS – CSL Behring
###Chair: Ted W. Love, MD (he/him/his) – Global Blood Therapeutics
Panelist: Gerard Smith, MD – Deep Track Capital
Panelist: Jim Birchenough, MD (he/him/his) – Wells Fargo Biopharmaceutical Investment Banking
Chair: Ted W. Love, MD (he/him/his) – Global Blood Therapeutics
### he/him/his @@@ Gerard Smith, MD – Deep Track Capital ### 1970699###Panelist###Principal###Deep Track Capital###Panelist: Gerard Smith, MD – Deep Track Capital
### @@@ Jim Birchenough, MD (he/him/his) – Wells Fargo Biopharmaceutical Investment Banking ### 1983797###Panelist###Vice Chairman###Wells Fargo Biopharmaceutical Investment Banking###Panelist: Jim Birchenough, MD (he/him/his) – Wells Fargo Biopharmaceutical Investment Banking
### he/him/hisPanelist: Rae Blaylark – Sickle Cell Foundation of MN
Panelist: Simone C. Uwan MD, MD – Sickle Cell Medical Advocacy Inc.
Panelist: Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency
Panelist: Rae Blaylark – Sickle Cell Foundation of MN
### @@@ Simone C. Uwan MD, MD – Sickle Cell Medical Advocacy Inc. ### 1671641###Panelist###Co-Founder and Director###Sickle Cell Medical Advocacy Inc.###Panelist: Simone C. Uwan MD, MD – Sickle Cell Medical Advocacy Inc.
### @@@ Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency ### 1886479###Panelist###Patient Engagement Coordinator/ Research Consultant ###Piedmont Health Services and Sickle Cell Agency ###Panelist: Justina G. Williams, MSW (she/her/hers) – Piedmont Health Services and Sickle Cell Agency
### she/her/hers